Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

New Insights Into Physiological and Pathophysiological Functions of Stanniocalcin 2

Frontiers in Endocrinology(2020)10.3389/fendo.2020.00172Source: DataRank Database

New Insights Into Physiological and Pathophysiological Functions of Stanniocalcin 2 is a research paper published in Frontiers in Endocrinology (2020). On theSindex it has a DataRank of 0. It has been cited 90 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access90 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 8.81)OA: goldTopics (50)Linked Datasets (22)DataCite Reuse (22)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Aditya Joshi ORCID

Live enrichment

PubMed:32296395 OpenAlex:https://openalex.org/W3013559756

National Institutes of Health

Grant: 5R01DK122028-06

Novel mechanism of aryl hydrocarbon receptor - mediated differential gene regulation

National Institutes of Health

Grant: 5K01DK102514-03

Characterization of cinnabarinic acid mediated cytoprotection upon liver injury

FWCI

8.81

Citation Percentile

1.0%

Citation Trend

2019

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fendo.2020.00172/pdf

GOLDhttps://www.frontiersin.org/articles/10.3389/fendo.2020.00172/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fendo.2020.00172/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fendo.2020.00172/full

journalhttps://doi.org/10.3389/fendo.2020.00172

Fields of Study

Physiological and biochemical adaptationsNeurobiology and Insect Physiology ResearchAquaculture Nutrition and GrowthBiologyMedicine0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Amino Acid SequenceAnimalsCalciumCloning, MolecularFishesGlycoproteinsHumansMammalsNeoplasmsPhosphatesPhylogenyBiomarkers, TumorIntercellular Signaling Peptides and Proteins

Keywords

BiologyCytoprotectionComputational biologyAngiogenesisHormoneBioinformaticsCell biologyCancer researchGeneticsEndocrinologyMammalsstanniocalcin 2apoptosisFishesRC648-665Diseases of the endocrine glands. Clinical endocrinologyPhosphatesNeoplasmsBiomarkers, TumorAnimalsHumansIntercellular Signaling Peptides and ProteinsCalciumAmino Acid SequenceCloning, MoleculardevelopmentPhylogenycalcium regulationGlycoproteins

Sustainable Development Goals

SDG 0: Life below water

Additional file 10 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505015.v1figshare

Additional file 10 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505015figshare

Additional file 11 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505018.v1figshare

Additional file 11 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505018figshare

Additional file 9 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505009.v1figshare

Additional file 9 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505009figshare

Additional file 8 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505006.v1figshare

Additional file 8 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505006figshare

Additional file 4 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23504994figshare

Additional file 3 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23504991.v1figshare

Additional file 3 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23504991figshare

Additional file 7 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505003.v1figshare

Additional file 6 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505000figshare

Additional file 7 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505003figshare

Additional file 2 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23504988.v1figshare

Additional file 5 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23504997figshare

Additional file 6 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23505000.v1figshare

Additional file 4 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23504994.v1figshare

Additional file 1 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23504985figshare

Additional file 2 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

10.6084/m9.figshare.23504988figshare